Purified anti-β-Amyloid, x-38 Recombinant Antibody, β-Amyloid x-38, QA18A68,BioLegend,605452

Host

Rabbit

Reactivity

Human

Application

Direct ELISA - Quality tested

Platform ID

BAB956776373

BioLegend

Headquarters

8999 BioLegend Way San Diego, CA 92121 United States

Contact

Tel: 1-858-455-9588
Fax: +49 (4131) 7023913

Email:

Product Specifications
Scientific Background

Specifications

NamePurified anti-β-Amyloid, x-38 Recombinant Antibody, β-Amyloid x-38, QA18A68
Cat. No.605452
HostRabbit
RRIDAB_2924612 (BioLegend Cat. No. 605452)
IsotypeRabbit IgG
ReactivityHuman
ApplicationDirect ELISA - Quality tested
ClonalityRecombinant
Clone NumberQA18A68
Concentration0.5 mg/mL
Targetbeta-Amyloid x-38
ImmunogenRecombinant fragment of human beta-amyloid 1-38
PurityThe antibody was purified by affinity chromatography.
FormulationPhosphate-buffered solution, pH 7.2, containing 0.09% sodium azide
StorageThe antibody solution should be stored undiluted between 2°C and 8°C.
Regulatory StatusResearch Use Only

Scientific Background

Amyloid beta (Aβ or Abeta) denotes peptides of 36-43 amino acids in length that are crucially involved in Alzheimer's disease as the main component of the amyloid plaques found in the brains of Alzheimer patients. The peptides result from the amyloid precursor protein (APP), which is cut by certain enzymes to yield Aβ. Aβ molecules can aggregate to form oligomers (known as "seeds") which are believed to be able to induce other Aβ molecules to also take the misfolded oligomeric form, leading to a chain reaction akin to a prion infection. The seeds or the resulting amyloid plaques are toxic to nerve cells. The other protein implicated in Alzheimer's disease, tau protein, also forms such prion-like misfolded oligomers, and there is some evidence that misfolded Aβ can induce tau to misfold.

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.